CIK 0001140859 · Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233079390
- Phone
- 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-25 | Clark Gina Executive Vice President | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −20,971 | 0 | ||
| 2023-09-21 | Donato Leslie E EVP & Chief Strategy Officer | Option exercise 10b5-1 | +3,386 | $86.09 | $292K | 8,735.75 |
| 2023-09-21 | Donato Leslie E EVP & Chief Strategy Officer | Sale 10b5-1 | −3,386 | $185.00 | $626K | 5,349.75 |
| 2023-09-21 | Donato Leslie E EVP & Chief Strategy Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,386 | 3,387 | ||
| 2023-09-12 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,500 | $77.53 | $814K | 268,467 |
| 2023-09-12 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,500 | $176.79 | $1.9M | 257,967 |
| 2023-09-12 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,500 | 75,000 | ||
| 2023-09-06 | Donato Leslie E EVP & Chief Strategy Officer | Option exercise 10b5-1 | +1,845 | $86.09 | $159K | 7,194.75 |
| 2023-09-06 | Donato Leslie E EVP & Chief Strategy Officer | Sale 10b5-1 | −1,845 | $175.00 | $323K | 5,349.75 |
| 2023-09-06 | Donato Leslie E EVP & Chief Strategy Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −1,845 | 6,773 | ||
| 2023-09-05 | Donato Leslie E EVP & Chief Strategy Officer | Sale 10b5-1 | −888 | $175.00 | $155K | 6,247.75 |
| 2023-09-05 | Donato Leslie E EVP & Chief Strategy Officer | Sale 10b5-1 | −898 | $175.00 | $157K | 5,349.75 |
| 2023-09-05 | Donato Leslie E EVP & Chief Strategy Officer | Option exercise 10b5-1 | +4,929 | $86.09 | $424K | 10,278.75 |
| 2023-09-05 | Donato Leslie E EVP & Chief Strategy Officer | Sale 10b5-1 | −4,929 | $175.00 | $863K | 5,349.75 |
| 2023-09-05 | Donato Leslie E EVP & Chief Strategy Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −4,929 | 8,618 | ||
| 2023-08-08 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,499 | $77.53 | $814K | 268,466 |
| 2023-08-08 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,499 | $186.19 | $2.0M | 257,967 |
| 2023-08-08 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,499 | 85,500 | ||
| 2023-08-03 | Walgreens Boots Alliance, Inc. 10% owner | Sale | −1,320,858 | $189.27 | $250.0M | 31,769,546 |
| 2023-08-03 | Walgreens Boots Alliance, Inc. 10% owner | Other acquisition · Forward sale contract (obligation to sell) | +262,500 | 262,500 |
Page 31 of 40 · 797 trades